Warner Chilcott Ovcon 35 chewable OC
Executive Summary
Warner Chilcott chewable oral contraceptiveOvcon 35 (.4 mg norethindrone/0.035 mg ethinyl estradiol) slated for a spring launch following Nov. 14 approval. Spearmint-flavored tablets can be swallowed whole or chewed when followed by a full glass of liquid, labeling says. Warner Chilcott, Galen's U.S. division, acquired the product from Bristol Myers-Squibb in 2000; Ovcon 35 holds roughly 2.5% of oral contraceptive market share. Company plans to eventually replace swallow-only tablets with chewable form...